Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on-treatment platelet reactivity: the OPTImal Management of Antithrombotic Agents (OPTIMA)-2 Trial

Ying, LH; Wang, J; Li, J; Teng, JZ; Zhang, XF; Ullah, I; Samee, A; Xu, K; Chen, J; Xu, L; Zhu, H; Li, JM; Yang, L; Wang, F; Fan, YS; Zhang, J; Lu, Y; Gong, XX; Shi, L; Eikelboom, JW; Li, CJ

Li, CJ (通讯作者)，Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, 300 Guangzhou Rd, Nanjing 210029, Peoples R China.

BRITISH JOURNAL OF HAEMATOLOGY, 2022; 196 (2): 424

Abstract

High on-treatment platelet reactivity (HOPR) is associated with increased risk of cardiovascular events in patients undergoing percutaneous coronary i......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索